BSE - Delayed Quote INR
NATCO Pharma Limited (NATCOPHARM.BO)
889.65
-14.00
(-1.55%)
At close: April 25 at 3:55:15 PM GMT+5:30
Breakdown
TTM
3/31/2024
3/31/2023
3/31/2022
3/31/2021
Operating Cash Flow
--
12,116,000
8,491,000
465,000
2,988,000
Investing Cash Flow
--
-10,327,000
-4,771,000
-53,000
-1,033,000
Financing Cash Flow
--
-2,469,000
-3,630,000
348,000
-1,857,000
End Cash Position
--
704,000
1,319,000
1,111,000
258,000
Capital Expenditure
--
-3,587,000
-2,056,000
-2,427,000
-2,546,000
Issuance of Capital Stock
--
--
--
--
1,000
Repayment of Debt
--
--
--
--
-484,000
Repurchase of Capital Stock
--
-2,537,000
-74,000
--
--
Free Cash Flow
--
8,529,000
6,435,000
-1,962,000
442,000
3/31/2021 - 3/2/2001
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
DIVISLAB.BO Divi's Laboratories Limited
6,009.20
-3.32%
SUVEN.BO Suven Life Sciences Limited
135.90
-3.48%
LINCOLN.NS Lincoln Pharmaceuticals Limited
593.20
-1.09%
DRREDDY.BO Dr. Reddy's Laboratories Limited
1,173.55
-2.32%
CAPLIPOINT.NS Caplin Point Laboratories Limited
1,806.70
-4.12%
AUROPHARMA.BO Aurobindo Pharma Limited
1,217.85
-3.16%
MOREPENLAB.BO Morepen Laboratories Limited
58.82
-5.43%
EMCURE.NS EMCURE PHARMACEUTICALS L
1,029.70
-4.05%
MOREPENLAB.NS Morepen Laboratories Limited
58.82
-5.46%
ZYDUSLIFE.BO Zydus Lifesciences Limited
859.10
-2.36%